Your browser doesn't support javascript.
loading
Suitability of transiently expressed antibodies for clinical studies: product quality consistency at different production scales.
Rodriguez-Conde, Sara; Inman, Sophie; Lindo, Viv; Amery, Leanne; Tang, Alison; Okorji-Obike, Uche; Du, Wenjuan; Bosch, Berend-Jan; Wichgers Schreur, Paul J; Kortekaas, Jeroen; Sola, Isabel; Enjuanes, Luis; Kerry, Laura; Mahal, Katharina; Hulley, Martyn; Daramola, Olalekan.
Afiliación
  • Rodriguez-Conde S; Cell Culture & Fermentation Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Inman S; Analytical Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Lindo V; Analytical Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Amery L; Late-Stage Formulation Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Tang A; Purification Process Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Okorji-Obike U; Analytical Sciences, Bioassay Biosafety and Impurities, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Du W; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • Bosch BJ; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • Wichgers Schreur PJ; Department of Virology and Molecular Biology, Wageningen Bioveterinary Research, Lelystad, The Netherlands.
  • Kortekaas J; Boehringer Ingelheim Animal Health, Saint Priest, France.
  • Sola I; Department of Molecular and Cell Biology, National Center of Biotechnology (CNB-CSIC), Campus Universidad Autónoma de Madrid, Spain.
  • Enjuanes L; Department of Molecular and Cell Biology, National Center of Biotechnology (CNB-CSIC), Campus Universidad Autónoma de Madrid, Spain.
  • Kerry L; Analytical Sciences, Bioassay Biosafety and Impurities, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Mahal K; Analytical Sciences, Bioassay Biosafety and Impurities, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Hulley M; Purification Process Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Daramola O; Cell Culture & Fermentation Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
MAbs ; 14(1): 2052228, 2022.
Article en En | MEDLINE | ID: mdl-35323099
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Coronavirus del Síndrome Respiratorio de Oriente Medio Idioma: En Revista: MAbs Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Coronavirus del Síndrome Respiratorio de Oriente Medio Idioma: En Revista: MAbs Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article